Geneva Partners’s Procter & Gamble PG Stock Holding History

Geneva Partners’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,937	Closed	-$358K	–	93
2017 Q3	$358K	Buy	+3,937	New	+$358K	0.28%	74
2016 Q2	$361K	Buy	+4,137	New	+$340K	0.32%	70

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TFM

Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geneva Partners's PG Position: Q4 2017 in Review

Geneva Partners sold out of Procter & Gamble (PG) in Q4 2017, closing a stake of 3,937 shares — an estimated $358K sold.

Geneva Partners first reported a position in PG in Q2 2016 and held it in 2 quarters. The position peaked at $361K in Q2 2016. 2,275 funds tracked by Wall St. Rank hold PG as of Q4 2017.

Geneva Partners reported no remaining Procter & Gamble position as of Q4 2017 after selling out during the quarter.
Geneva Partners sold 3,937 Procter & Gamble shares in Q4 2017, an estimated $358K.
Geneva Partners first reported a position in Procter & Gamble in Q2 2016 and held it in 2 quarters.
Geneva Partners's Procter & Gamble position peaked at $361K in Q2 2016.
2,275 funds tracked by Wall St. Rank held Procter & Gamble as of Q4 2017.

Based on Geneva Partners's 13F filing for Q4 2017, filed 8 Feb 2018.